The CME Vacations® 2 Minute Update
How often do we interrupt sleep in hospitalized...
Hospitalized older adults were woken nearly 5 times a night with under 4 hours of uninterrupted sleep—and it didn't improve over their stay.
How often do we interrupt sleep in hospitalized...
Hospitalized older adults were woken nearly 5 times a night with under 4 hours of uninterrupted sleep—and it didn't improve over their stay.
Can air filters improve COPD symptoms?
A randomized trial found home HEPA filters improved COPD symptoms and cut exacerbations, in patients who used them consistently.
Can air filters improve COPD symptoms?
A randomized trial found home HEPA filters improved COPD symptoms and cut exacerbations, in patients who used them consistently.
Does driving prevent dementia?
Ambulance and taxi drivers had roughly half the Alzheimer's mortality of other occupations in a study of nearly 9 million deaths.
Does driving prevent dementia?
Ambulance and taxi drivers had roughly half the Alzheimer's mortality of other occupations in a study of nearly 9 million deaths.
Can Vitamin K2 prevent leg cramps?
A randomized trial found vitamin K2 cut nocturnal leg cramps from about 2.65 to under 1 per week—cheap, simple, and low-risk.
Can Vitamin K2 prevent leg cramps?
A randomized trial found vitamin K2 cut nocturnal leg cramps from about 2.65 to under 1 per week—cheap, simple, and low-risk.
In COPD, do inhaled corticosteroids save lives?
A meta-analysis of 60 trials and 103,000 patients found inhaled corticosteroids lowered all-cause mortality in COPD, despite raising pneumonia risk.
In COPD, do inhaled corticosteroids save lives?
A meta-analysis of 60 trials and 103,000 patients found inhaled corticosteroids lowered all-cause mortality in COPD, despite raising pneumonia risk.
In stage 5 CKD, do SGLT2 inhibitors prevent pro...
In a 47,000-patient study, stage 5 CKD patients on SGLT2 inhibitors were far less likely to progress to dialysis—though they were sicker at baseline.
In stage 5 CKD, do SGLT2 inhibitors prevent pro...
In a 47,000-patient study, stage 5 CKD patients on SGLT2 inhibitors were far less likely to progress to dialysis—though they were sicker at baseline.